Welcome! Log into your account
Forgot your password? Get help
Recover your password
A password will be e-mailed to you.
Ipsen partnered with MD Anderson Cancer Center to develop new cancer drug
Ipsen, a global biopharmaceutical group, and The University of Texas MD Anderson Cancer Center announced a global licensing and joint development agreement for a pre-clinical oncology drug candidate.
Arix Bioscience and Ipsen start cooperation on innovative therapies
Arix Bioscience, a global healthcare and life science company, and Ipsen, a global specialty-driven biopharmaceutical company announced a strategic agreement to develop and commercialise innovative therapies.
Rafarma – a full cycle pharmaceutical enterprise
Binnopharm – full-cycle biopharmaceutical faciliti...
Pharmacor Production Ltd.
V.P. Filatov Pharmaceutical Plant
R-Pharm – Russian High-Tech Pharmaceutical Enterprise
PIQ-PHARMA Group of Companies
GMP Inspection practice: a case for global benchmarking, con...
Merck KGaA will lead Global Oncology Big Data Alliance
Conference GEP-Russia 2017: Sterile Forms and Biotechnology
MIPT delivers world’s first biosensor chips of unprecedented...
German CDMO HERMES PHARMA receives Russian GMP certification...
Amgen will transfer technology for manufacturing of blinatum...
Subscribe to Newsletter!
© GMP news